Precision medicine in chronic disease management: The multiple sclerosis BioScreen
- Gourraud, Pierre‐Antoine;
- Henry, Roland G;
- Cree, Bruce AC;
- Crane, Jason C;
- Lizee, Antoine;
- Olson, Marram P;
- Santaniello, Adam V;
- Datta, Esha;
- Zhu, Alyssa H;
- Bevan, Carolyn J;
- Gelfand, Jeffrey M;
- Graves, Jennifer S;
- Goodin, Douglas S;
- Green, Ari J;
- von Büdingen, H‐Christian;
- Waubant, Emmanuelle;
- Zamvil, Scott S;
- Crabtree‐Hartman, Elizabeth;
- Nelson, Sarah;
- Baranzini, Sergio E;
- Hauser, Stephen L
- et al.
Published Web Location
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214886/Abstract
We present a precision medicine application developed for multiple sclerosis (MS): the MS BioScreen. This new tool addresses the challenges of dynamic management of a complex chronic disease; the interaction of clinicians and patients with such a tool illustrates the extent to which translational digital medicine-that is, the application of information technology to medicine-has the potential to radically transform medical practice. We introduce 3 key evolutionary phases in displaying data to health care providers, patients, and researchers: visualization (accessing data), contextualization (understanding the data), and actionable interpretation (real-time use of the data to assist decision making). Together, these form the stepping stones that are expected to accelerate standardization of data across platforms, promote evidence-based medicine, support shared decision making, and ultimately lead to improved outcomes.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.